9:00 am Check-In & Light Breakfast
Workshop A
9:30 am Collaborating on Industry-Uniting Strategies to Support Bioactive Ingredient Innovation
Synopsis
This is your premier opportunity to unite with R&D and regulatory teams from other infant formula manufacturers and ingredient developers in an interactive and discussion-based session to:
- Identify consistent and consolidated regulatory strategies for bioactive ingredients and discuss the regulatory requirements of bringing new infant formulas to market
- Leverage lessons learned from successful and failed conversations to inform future approaches
- Enhance synergy between regulatory and R&D teams to ensure efficient feedback loops and decision-making
- Reflecting on historical perspectives surrounding infant formula development
12:30 pm Networking Lunch
Workshop B
1:30 pm Optimizing Clinical Trial Design & Efficiency Through Suitable Endpoint Identification
Synopsis
Uncertainty exists around the role of certain human breast milk components, and therefore how bioactive ingredients can specifically transform infant formula. Relevant endpoint selection is vital in clinical trial design to support dossier compilation. This workshop is your opportunity to deep dive into:
- Uncovering clinical endpoints that measure sensory, cognitive, neurological, and immunological function based on the application of the formula
- Selecting relevant endpoints to evaluate toxicity and microbiome impact
- Examining how these endpoints can be measured for reproducibility, developing standardized panels of expected approaches and experimental methods